Emerald Mutual Fund Advisers Trust Assembly Biosciences, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$4.87 - $17.29 $1.48 Million - $5.27 Million	-304,623 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$15.08 - $27.04 $597,831 - $1.07 Million	-39,644 Reduced 11.52%	304,623 $5.01 Million
Q2 2020 Jul 28, 2020	BUY	$14.57 - $23.96 $321,530 - $528,749	22,068 Added 6.85%	344,267 $8.03 Million
Q1 2020 Apr 30, 2020	BUY	$10.27 - $21.23 $1.65 Million - $3.42 Million	160,860 Added 99.7%	322,199 $4.78 Million
Q4 2019 Jan 29, 2020	SELL	$8.36 - $23.81 $2.1 Million - $5.99 Million	-251,404 Reduced 60.91%	161,339 $3.3 Million
Q3 2019 Oct 31, 2019	SELL	$9.83 - $14.82 $53,082 - $80,028	-5,400 Reduced 1.29%	412,743 $4.06 Million
Q1 2019 May 01, 2019	BUY	$17.7 - $24.93 $871,371 - $1.23 Million	49,230 Added 13.34%	418,143 $8.23 Million
Q3 2018 Oct 31, 2018	BUY	$34.41 - $44.23 $5.71 Million - $7.33 Million	165,812 Added 81.64%	368,913 $13.7 Million
Q2 2018 Jul 31, 2018	BUY	$39.21 - $50.29 $3.62 Million - $4.64 Million	92,353 Added 83.39%	203,101 $7.96 Million
Q1 2018 Apr 26, 2018	SELL	$41.7 - $64.16 $1.79 Million - $2.76 Million	-43,034 Reduced 27.98%	110,748 $5.44 Million
Q4 2017 Feb 06, 2018	BUY	$28.58 - $49.91 $4.4 Million - $7.68 Million	153,782	153,782 $6.96 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.